Purchase Order 36C25719P1577
- Not listed
- The U.S. Department of Veterans Affairs (VA) awarded a one-year delivery order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of reagents and consumables. The $140,048.65 firm-fixed-price contract does not have a set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. This delivery order is placed against Roche's Indefinite Delivery...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide reagents. The contract has a 5-year ordering period and a potential value of $1,644,684.16. The contract was awarded on May 24, 2019, with a completion date of May 23, 2023. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics,...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $103,792.50 delivery order contract for COBAS reagents to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. This order was placed under Roche's existing General Services Administration (GSA) Schedule...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the provision of blood reagents on a cost-per-test basis. The contract has a potential value of $186,725.66 and was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6. The contract is a delivery order under Roche's General Services Administration (GSA) Schedule 66-III contract for critical laboratory analyzers and does...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awarded a firm fixed price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for $265,413.74 in reagents and stains. The contract does not have a set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Through multiple General Services...
- The Department of Veterans Affairs Veterans Health Administration awarded a $480,111.25 firm fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, to provide chemistry reagents and supplies. This award was made through Roche's General Services Administration (GSA) Schedule contract for critical analyzers and laboratory equipment. The delivery order has a completion date of December 31, 2019 and is not designated as a set-aside contract. Roche...
- This is a $102,970.11 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for REAGENTS and has no set-aside designation. Roche Diagnostics has provided critical medical equipment, supplies, and services to the VA, Department of Defense, Department of Health and Human Services, and...
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $222,288.37, is a delivery order under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration (GSA) Schedule contract. The contract is for the provision of molecular infectious disease reagents to the Department of Veterans Affairs' (VA)...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order contract to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide annual payment for cost per reportable results and reagent/supply replenishment. The contract, which does not have a set-aside designation, has a potential value of $226,857.13 and a completion date of May 31, 2020. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics,...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order contract to Roche Diagnostics Corporation for in vitro diagnostic products and services. The $326,288.57 contract is funded through the Veterans Integrated Service Network 6 and provides critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to VA hospitals. The contract was not set aside and is based on Roche's existing General Services...
The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order contract to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for $126,072.46 in reagents. The contract has a completion date of September 29, 2020 and was awarded on September 30, 2019. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract was not set aside for any specific business type. Roche Diagnostics has held multiple General Services Administration (GSA) Schedule contracts and has provided critical care analyzers, reagents, test kits, and associated equipment and services to various federal agencies including the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($21k) | 3/11/21 | |
| Not listed | Not listed | $146.7k | 9/30/19 |